Chang J - Search Results

1

Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary.

O'Shaughnessy JA, Ljung BM, Dooley WC, Chang J, Kuerer HM, Hung DT, Grant MD, Khan SA, Phillips RF, Duvall K, Euhus DM, King BL, Anderson BO, Troyan SL, Kim J, Veronesi U, Cazzaniga M. O'Shaughnessy JA, et al. Among authors: chang j. Cancer. 2002 Jan 15;94(2):292-8. doi: 10.1002/cncr.10238. Cancer. 2002. PMID: 11900214 Free article. Review. No abstract available.

2

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Chang J, et al. Cancer. 2003 Feb 1;97(3):545-53. doi: 10.1002/cncr.11083. Cancer. 2003. PMID: 12548595 Free article.

3

Pharmacogenetics of breast cancer: toward the individualization of therapy.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Cancer Invest. 2009 Aug;27(7):699-703. doi: 10.1080/07357900903152473. Cancer Invest. 2009. PMID: 19637041 No abstract available.

4

Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.

Chen AC, Paulino AC, Schwartz MR, Rodriguez AA, Bass BL, Chang JC, Teh BS. Chen AC, et al. Among authors: chang jc. Br J Cancer. 2014 Jul 29;111(3):619-22. doi: 10.1038/bjc.2014.301. Epub 2014 Jun 12. Br J Cancer. 2014. PMID: 24921921 Free PMC article.

5

Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.

Young CD, Zimmerman LJ, Hoshino D, Formisano L, Hanker AB, Gatza ML, Morrison MM, Moore PD, Whitwell CA, Dave B, Stricker T, Bhola NE, Silva GO, Patel P, Brantley-Sieders DM, Levin M, Horiates M, Palma NA, Wang K, Stephens PJ, Perou CM, Weaver AM, O'Shaughnessy JA, Chang JC, Park BH, Liebler DC, Cook RS, Arteaga CL. Young CD, et al. Among authors: chang jc. Mol Cell Proteomics. 2015 Jul;14(7):1959-76. doi: 10.1074/mcp.M115.049783. Epub 2015 May 7. Mol Cell Proteomics. 2015. PMID: 25953087 Free PMC article. Clinical Trial.

6

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM. Chang J, et al. Breast Cancer Res Treat. 2001 Sep;69(2):101-13. doi: 10.1023/a:1012203917104. Breast Cancer Res Treat. 2001. PMID: 11759816 Review.

7

Reversible and irreversible cardiac dysfunction associated with trastuzumab in breast cancer.

Tham YL, Verani MS, Chang J. Tham YL, et al. Among authors: chang j. Breast Cancer Res Treat. 2002 Jul;74(2):131-4. doi: 10.1023/a:1016140729725. Breast Cancer Res Treat. 2002. PMID: 12186373

8

Genomic approaches in the management and treatment of breast cancer.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Br J Cancer. 2005 Feb 28;92(4):618-24. doi: 10.1038/sj.bjc.6602410. Br J Cancer. 2005. PMID: 15714204 Free PMC article. Review.

9

The promise of microarrays in the management and treatment of breast cancer.

Chang JC, Hilsenbeck SG, Fuqua SA. Chang JC, et al. Breast Cancer Res. 2005;7(3):100-4. doi: 10.1186/bcr1018. Epub 2005 Apr 1. Breast Cancer Res. 2005. PMID: 15987438 Free PMC article. Review.

10

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.

Tham YL, Gomez LF, Mohsin S, Gutierrez MC, Weiss H, Hilsenbeck SG, Elledge RM, Chamness GC, Osborne CK, Allred DC, Chang JC. Tham YL, et al. Breast Cancer Res Treat. 2005 Dec;94(3):279-84. doi: 10.1007/s10549-005-9020-z. Breast Cancer Res Treat. 2005. PMID: 16261403 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,576 results

Search Page

Filters